KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Tax Provisions (2016 - 2025)

Historic Tax Provisions for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $33.3 million.

  • West Pharmaceutical Services' Tax Provisions fell 951.09% to $33.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $121.6 million, marking a year-over-year increase of 1311.63%. This contributed to the annual value of $121.6 million for FY2025, which is 1311.63% up from last year.
  • West Pharmaceutical Services' Tax Provisions amounted to $33.3 million in Q4 2025, which was down 951.09% from $34.0 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Tax Provisions peaked at $44.2 million during Q2 2022, and registered a low of $12.0 million during Q3 2021.
  • Over the past 5 years, West Pharmaceutical Services' median Tax Provisions value was $29.8 million (recorded in 2023), while the average stood at $28.7 million.
  • Data for West Pharmaceutical Services' Tax Provisions shows a peak YoY increase of 10187.5% (in 2021) and a maximum YoY decrease of 4312.8% (in 2021) over the last 5 years.
  • West Pharmaceutical Services' Tax Provisions (Quarter) stood at $34.2 million in 2021, then decreased by 15.5% to $28.9 million in 2022, then grew by 19.38% to $34.5 million in 2023, then increased by 6.67% to $36.8 million in 2024, then fell by 9.51% to $33.3 million in 2025.
  • Its last three reported values are $33.3 million in Q4 2025, $34.0 million for Q3 2025, and $30.2 million during Q2 2025.